NL-OMON51042
Completed
Not Applicable
Accurate multiple sclerosis atrophy measurement system - AMS2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Multiple Sclerosis
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •MS patient group:
- •1\. Clincally definite relapsing\-remitting, secondary progressive, primary
- •progressive MS, according to McDonald criteria (2017\).
- •2\. 18 to 70 years old.
- •3\. Be able to undergo 6 MRI scans (scan and rescan on three different MR
- •scanners) in one day
- •4\. Written informed consent
- •Healthy controls:
- •1\. 18 to 70 years old.
- •2\. Written informed consent
Exclusion Criteria
- •1\. Inability to undergo MRI, e.g. metal objects in or around the body,
- •claustrophobia or inability to lie still in the
- •2\. Pregnant
- •3\. Past or current clinically relevant non\-MS neurological or psychiatric
- •disorder(s)
- •4\. Past or current clinically relevant (auto)immune disorder(s)
- •5\. Colleagues from the same department, people directly involved in the study
- •or people with relevant relations to the aforementioned people (e.g. partner,
- •parent, sibling or child etc.).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Standardization of brain atrophy measurement in MS patientsMultiple Sclerosis10012303NL-OMON43474Vrije Universiteit Medisch Centrum35
Completed
Not Applicable
Proxy measurements in Multiple SclerosisMultiple Sclerosis10029317NL-OMON31939Vrije Universiteit Medisch Centrum300
Completed
Not Applicable
3 Meter Backwards Walk Test and Multiple SclerosisMultiple SclerosisWalking, DifficultyBalance; DistortedNCT04004026Sanko University40
Completed
Not Applicable
Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance ImagingMSmultiple sclerosis1000381610012303NL-OMON40083Vrije Universiteit Medisch Centrum30
Active, not recruiting
Not Applicable
Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIPPatients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.MedDRA version: 8.1Level: LLTClassification code 10028245Term: Multiple sclerosisEUCTR2006-001337-17-DEMax-Planck-Institute of Psychiatry